These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 645719)

  • 21. Pitfalls and errors in drug monitoring: pharmacokinetic aspects.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):559-66. PubMed ID: 6664156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Choosing optimal sampling times for therapeutic drug monitoring.
    Schumacher GE
    Clin Pharm; 1985; 4(1):84-92. PubMed ID: 3971691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics as an aid in the interpretation of toxicity tests.
    Hammer R; Boxler G
    Arzneimittelforschung; 1977; 27(3):555-7. PubMed ID: 577420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic concepts and applications affecting the clinical laboratory: I. General concepts and applications.
    Schumacher GE
    Am J Med Technol; 1981 Mar; 47(3):157-61. PubMed ID: 7223760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Estimation of pharmacokinetic constants in irregular repeated drug administration (author's transl)].
    Ringwelski L; Krause D
    Arzneimittelforschung; 1978; 28(10):1766-70. PubMed ID: 582681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Midpoint back-extrapolation method for the rapid estimation of drugs' volume of distribution and dosage adjustment exhibiting multicompartmental characteristics.
    Chiou WL; Huang SM; Huang YC
    Int J Clin Pharmacol Ther Toxicol; 1980 Jan; 18(1):1-4. PubMed ID: 7364527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A simple electronic circuit for simulation of pharmacokinetic processes.
    Danek A; Poczatek J
    Arzneimittelforschung; 1976; 26(3):321-4. PubMed ID: 989320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bayesian hierarchical modeling of receptor occupancy in PET trials.
    Vandenhende F; Renard D; Nie Y; Kumar A; Miller J; Tauscher J; Witcher J; Zhou Y; Wong DF
    J Biopharm Stat; 2008; 18(2):256-72. PubMed ID: 18327720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TK Modeler version 1.0, a Microsoft® Excel®-based modeling software for the prediction of diurnal blood/plasma concentration for toxicokinetic use.
    McCoy AT; Bartels MJ; Rick DL; Saghir SA
    Regul Toxicol Pharmacol; 2012 Jul; 63(2):333-43. PubMed ID: 22504463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steady-state dosage regimen calculations in linear pharmacokinetics.
    Iliadis A; Bruno R; Cano JP
    Int J Biomed Comput; 1986 May; 18(3-4):167-82. PubMed ID: 3755120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug dosage in renal disease.
    Dettli L
    Clin Pharmacokinet; 1976; 1(2):126-34. PubMed ID: 797495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The time course of drug effects.
    Al-Sallami HS; Pavan Kumar VV; Landersdorfer CB; Bulitta JB; Duffull SB
    Pharm Stat; 2009; 8(3):176-85. PubMed ID: 19626596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multicompartment pharmacokinetic analysis and simulations using a programmable calculator.
    Niazi S
    Int J Biomed Comput; 1979 May; 10(3):245-55. PubMed ID: 489156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Facilitating pharmacokinetic studies in children: a new use of dried blood spots.
    Patel P; Mulla H; Tanna S; Pandya H
    Arch Dis Child; 2010 Jun; 95(6):484-7. PubMed ID: 20501544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Drug accumulation and dose finding (authors' transl)].
    Kurz H
    Arzneimittelforschung; 1977 Feb; 27(2A):250-3. PubMed ID: 577170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative relationships between dynamics and kinetics of drugs: a systems dynamics approach.
    van Rossum JM; Burgers JP
    Drug Metab Rev; 1984; 15(1-2):365-82. PubMed ID: 6378560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further considerations of the "single-point single-dose" method to estimate individual maintenance dosage requirements.
    Unadkat JD; Rowland M
    Ther Drug Monit; 1982; 4(2):201-8. PubMed ID: 7101388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Properties of the one-compartmental model with nonlinear elimination.
    Wang CY
    Arzneimittelforschung; 1977; 27(12):2368-71. PubMed ID: 580052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Model building in pharmacokinetics/Part V: Simulation of blood level curves following repetitive dosing and their experimental verification (author's transl)].
    Hammer R; Bozler G; Heinzel G; Koss FW
    Arzneimittelforschung; 1977; 27(4a):928-31. PubMed ID: 577860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The single-point method of dosage prediction: pharmacokinetic basis and method optimization.
    Love BL; Tsuei SE; Thomas J; Nation RL
    Biopharm Drug Dispos; 1982; 3(3):191-201. PubMed ID: 7139060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.